Here are four takeaways:
1. Southern Spine reports its system reduces intraoperative complications, provides quicker recovery times and lowers adjacent segment disease.
2. The company also notes the StabiLink MIS Interlaminar Spinal Fixation System offers similar rigidity, fusion rates and patient-reported outcomes when compared to pedicle screw fusion.
3. The StabiLink MIS Interlaminar Spinal Fixation System possesses FDA clearance and the CE mark.
4. Surgeons have used the system in thousands of procedures, so far.
More articles on devices:
OrthoPediatrics Corp. closes initial public offering of 4.6M shares: 5 insights
Arthrex to build $30M manufacturing plant in South Carolina: 5 insights
Johnson & Johnson medical device segment reports 4.9% sales growth in 2Q 2017 – to see greater growth in 3Q
